SCHEMBL20088485

SCHEMBL20088485

[N-]=[N+]=NCOC1CC(n2cc(C#CCNC(=O)COCCOC(COc3cccc(C(=O)NCCN)c3)N=[N+]=[N-])c3c(N)ncnc32)OC1CO

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.36
▸ NAE1 Q13564 2/20 0.30
▸ UBA1 P22314 1/20 0.30
▸ UBA3 Q8TBC4 1/20 0.30
▸ SAE1 Q9UBE0 1/20 0.30
▸ UBA2 Q9UBT2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17523546 0.93 CA2 (0.34) CA2
SCHEMBL14806825 0.93 CA2 (0.34) CA2
SCHEMBL14820596 0.93 CA2 (0.34) CA2
SCHEMBL21022513 0.92 CA2 (0.33) CA2
SCHEMBL24518381 0.91 CA2 (0.34) CA2
SCHEMBL25541258 0.89 CA2 (0.33) CA2
SCHEMBL17227477 0.89 CA2 (0.33) CA2
SCHEMBL21123041 0.88 CA2 (0.35) CA2
SCHEMBL18412182 0.87 CA2 (0.34) CA2
SCHEMBL17636632 0.87 CA2 (0.32) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239909-B2 Polymethine compounds with long stokes shifts and their use as fluorescent labels ILLUMINA CAMBRIDGE LIMITED (GB) 2019-03-26 — — US disclosed
US-20180111957-A1 POLYMETHINE COMPOUNDS WITH LONG STOKES SHIFTS AND THEIR USE AS FLUORESCENT LABELS ILLUMINA CAMBRIDGE LTD. (GB) 2018-04-26 — — US disclosed
US-20180111957-A1 POLYMETHINE COMPOUNDS WITH LONG STOKES SHIFTS AND THEIR USE AS FLUORESCENT LABELS ILLUMINA CAMBRIDGE LTD. (GB) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180111957-A1 POLYMETHINE COMPOUNDS WITH LONG STOKES SHIFTS AND THEIR USE AS FLUORESCENT LABELS POLRMT, FBL, NOP2 CA2 3778/4885NAE1 2286/4885UBA1 3808/4885
US-10239909-B2 Polymethine compounds with long stokes shifts and their use as fluorescent labels POLRMT, FBL, NOP2 CA2 3778/4885NAE1 2286/4885UBA1 3808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback